Conversely, the total DSG2 level was significantly decreased in all ARVD/C samples, compared to controls and normal heart, regardless of the disease-causing mutation (Figure 2a). This evidence concerns the gene DSG2 and arrhythmogenic right ventricular cardiomyopathy.